Abstract
AIM: A hiatal hernia (HH) complicates the diagnosis and surgical treatment of gastroesophageal junction (GEJ) cancer. This study aimed to investigate the effect of HH on the survival outcomes of GEJ cancer patients. METHODS: This single-center study reviewed clinical data of 78 patients with GEJ adenocarcinoma who underwent R0 resection from 2008 to 2017. The patients were divided into two groups according to whether they presented with or without HH: the HH (+) group (n = 46) and the HH (-) group (n = 32). RESULTS: Patients in the HH (+) group were older than those in the HH (-) group (69.0 vs 67.5 years, P = .018). Regarding surgical outcomes, intra-abdominal infectious complications was more common in the HH (+) group than in the HH (-) group (23.9% vs 9.4%, respectively; P = .089), particularly abscess formation (17.4% vs 3.1%, respectively; P = .036). Neither overall survival (OS) nor relapse-free survival (RFS) differed between the two groups. However, survival rates were significantly worse in a subset of patients with T3-4 disease (OS: log-rank, P = .036) (RFS: log-rank, P = .040) in the HH (+) group. In a multivariate analysis for OS in this cohort, HH was an independent prognostic factor (hazard ratio 3.60; 95% confidence interval 1.06-11.9, P = .032). CONCLUSION: Hiatal hernia may adversely affect surgical and survival outcomes in patients with GEJ cancer. Thus, surgical strategy must be carefully considered in these patients.